About 2 results found for searched term "Pinatuzumab" (0.135 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24766 | Pinatuzumab | Integrin |
| Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody drug conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL). | ||
| M40940 | Pinatuzumab vedotin | Drug-Linker Conjugates for ADC |
| Pinatuzumab vedotin is an antibody-drug coupling (ADC) targeting CD22 containing the microtubule inhibitor monomethylauristatin E (MMAE) for studies related to diffuse large B-cell lymphoma. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
